Author

Jack L. Schwartz

University of Rochester Medical Center;ORCID 0009-0003-0155-4427Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jack L. Schwartz1 paper · University of Rochester Medicine

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:imaging· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Eric J. WagneriD· 1 shared Erica SquireiD· 1 shared Fredric P. ManfredssoniD· 1 shared Harris A. GelbardiD· 1 shared Herman LiiD· 1 shared Ivette M. SandovaliD· 1 shared Luis Daniel Bernal-CondeiD· 1 shared Madeline K. WashburniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Eric J. WagnerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dual kinase inhibition provides early clues to restoration of neuroimmune homeostasis in an AAV-haSyn model of Parkinsons disease

Wesley Chiang, Ivette M. Sandoval, Herman Li, Luis Daniel Bernal-Conde, Rene Squire, Madeline K. Washburn, Jack L. Schwartz, Erica Squire, Eric J. Wagner, Fredric P. Manfredsson, Harris A. Gelbard

This study shows that dual inhibition of MLK3 and LRRK2 with URMC-099 reduces PD pathology and motor deficits in an AAV-haSyn rat model.

bioRxiv · Nov 7, 2026 · PreprintNeuroscience